Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure (HF), yet torsemide has been shown to have less inter- and intra-individual variation in ...

Treatment of ascites is initially based on diuretics, but randomized studies assessing the efficacy of different combinations of diuretics are very scarce. Angeli et al. compared the efficacy and ...

The privately held Swiss biopharma company's Lasix ONYU is a combination product consisting of a novel high-concentration formulation of the diuretic furosemide and the Gerresheimer on-body drug ...

Lasix ONYU is a combination product consisting of a novel high-concentration formulation of the diuretic furosemide and the Gerresheimer on-body drug delivery device. Tentative Approval indicates here ...

SQ Innovation will be to file for full FDA marketing approval once the regulatory exclusivity period of a competing product elapses in October 2025. Image credit: Tada Images via Shutterstock.